The Efficacy and Safety of Myelophil, an Ethanol Extract Mixture of Astragali Radix and Salviae Radix, for Chronic Fatigue Syndrome: A Randomized Clinical Trial

Conclusion: These results support the hypothesis that Myelophil can be a therapeutic candidate to manage CFS and provide the rationale for its progression to a phase 3 clinical trial.Clinical Trial Registration:www.ClinicalTrials.gov, identifier KCT0002317.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research